article thumbnail

A Mixed Studies Literature Review on Mental Health Perceived Needs of Family Physicians in Infectious Catastrophes [Education and training]

Annals of Family Medicine

This can potentially compromise their ability to provide optimal patient care. ’s (2006) framework. Employing thematic analysis, seven distinct themes emerged, which were then classified across four overarching levels: societal, institutional, organizational, and individual.

article thumbnail

The Massachusetts Avenue of health reform

The Health Policy Exchange

At that point, he had not yet committed to the individual health insurance mandate that made his reforms possible but later became a political liability during his Presidential campaigns. in 2006 to 1.9% Together, Romney and Kennedy approached the George W. Health reform in Massachusetts has been judged a mixed success.

Insurance 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How to Run DMC? It’s Tricky – FDA’s New Draft Guidance Provides Updated Recommendations on How to Best Use Data Monitoring Committees in Clinical Trials

FDA Law Blog

Clissold — The trio of CDER, CBER, and CDRH released a new draft guidance titled “ Use of Data Monitoring Committees in Clinical Trials ” that revises the 2006 guidance “Establishment and Operation of Clinical Trial Data Monitoring Committees” and, when final, will replace the 2006 guidance.

Clinic 105
article thumbnail

How hospitals can cut admission delays by 30%

Today's Hospitalist

Those interventions included standardizing both bed assignments and nursing handoffs while having ED providers—not an inpatient team—enter skeletal orders when deciding to admit a patient. That checklist includes patient demographics and the individual patient’s clinical needs. Based in Bucks County, Pa.,

article thumbnail

A Question 30 Years in the Making: Would a Final LDT Rule Withstand Judicial Scrutiny?

FDA Law Blog

The PR first sets out to establish that it has authority to regulate in vitro diagnostic “test systems” as devices, and not just the system’s individual components, such as reagents, instruments, specimen collection devices, and software.

article thumbnail

Draft LASIK Guidance: Why Did FDA Issue New Labeling Recommendations for Products that Already Have PMA Approved Labeling?

FDA Law Blog

In an appendix, FDA provides a model “decision check list” for patients. You should place your initials in the location provided next to each item to indicate that you have read and understood the item. This document is intended only to provide clarity to the public regarding existing requirements under the law.”

article thumbnail

What every physician should know about care experience (and why it matters)

Permanente Medicine

I joined SCPMG straight from residency in 2006. I think sometimes we don’t necessarily realize the importance in the role that each of us individually as physicians can have with patients both within the exam room but also globally. Dr. Marcos, tell us who you are and what you do. WM: Like you, I’m a family physician.

IT 52